litlas
Log inCreate account

Weidong Han

Active 2007–2026

220
Papers
25,122
Citations
89
h-index
196
i10-index

Citations

Citations per year for Weidong Han1948: 1 citations1968: 1 citations1973: 1 citations1984: 1 citations1993: 1 citations1999: 1 citations2003: 1 citations2005: 2 citations2007: 4 citations2008: 10 citations2009: 13 citations2010: 11 citations2011: 27 citations2012: 48 citations2013: 60 citations2014: 96 citations2015: 122 citations2016: 178 citations2017: 262 citations2018: 302 citations2019: 1,006 citations2020: 1,271 citations2021: 1,650 citations2022: 1,666 citations2023: 1,392 citations2024: 2,049 citations2025: 1,338 citations2026: 81 citations1949–1967: no citations, so these years are not shown1969–1972: no citations, so these years are not shown1974–1983: no citations, so these years are not shown1985–1992: no citations, so these years are not shown1994–1998: no citations, so these years are not shown2000–2002: no citations, so these years are not shown2004: no citations, so this year is not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,966 citing papers, 36.8% of this breakdownUnited States: 2,471 citing papers, 18.3% of this breakdownGermany: 474 citing papers, 3.5% of this breakdownItaly: 395 citing papers, 2.9% of this breakdownUnited Kingdom: 394 citing papers, 2.9% of this breakdownIran: 341 citing papers, 2.5% of this breakdownIndia: 326 citing papers, 2.4% of this breakdownSouth Korea: 303 citing papers, 2.3% of this breakdownSpain: 248 citing papers, 1.8% of this breakdownFrance: 241 citing papers, 1.8% of this breakdownAustralia: 230 citing papers, 1.7% of this breakdownCanada: 227 citing papers, 1.7% of this breakdown
0%36.8%Other 21.4%

Institutions

Fields

  • Medicine51.8%
  • Biochemistry, Genetics and Molecular Biology29.6%
  • Immunology and Microbiology8.1%
  • Engineering3.2%
  • Computer Science2.3%
  • Materials Science1.2%
  • Other3.8%

Topics

  • CAR-T cell therapy research7.7%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Immune Cell Function and Interaction3.2%
  • Autophagy in Disease and Therapy3%
  • Immunotherapy and Immune Responses2.7%
  • MicroRNA in disease regulation2.6%
  • Other77.1%

Coauthors

All papers

Open in search
  1. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy

    Authors: Mengze Lv, Meixia Chen, Rui Zhang, Wen Zhang, Chenguang Wang, Yan Zhang, Xiaoming Wei, Yukun Guan, Jiejie Liu, Kaichao Feng, Miao Jing, Xurui Wang, Yun‐Cai Liu, Qian Mei, Weidong Han, Zhengfan Jiang - Cell Research 2020 cited by 1,014

  2. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells

    Authors: Zhiwei Zhou, Huabin He, Kun Wang, Xuyan Shi, Yupeng Wang, Ya Su, Yao Wang, Da Li, Wang Liu, Yongliang Zhang, Lianjun Shen, Weidong Han, Lin Shen, Jingjin Ding, Feng Shao - Science 2020 cited by 1,338

  3. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer

    Authors: Baolin Liu, Xueda Hu, Kaichao Feng, Ranran Gao, Zhiqiang Xue, Sujie Zhang, Yuanyuan Zhang, Emily Corse, Yi Hu, Weidong Han, Zemin Zhang - Nature Cancer 2021 cited by 474

  4. TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors

    Authors: Na Tang, Chen Cheng, Xingying Zhang, Miaomiao Qiao, Na Li, Wei Mu, Xiao-Fei Wei, Weidong Han, Haoyi Wang - JCI Insight 2020 cited by 390

  5. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b

    Authors: Dongdong Ti, Haojie Hao, Chuan Tong, Jiejie Liu, Liang Dong, Jingxi Zheng, Yali Zhao, Huiling Liu, Xiaobing Fu, Weidong Han - Journal of Translational Medicine 2015 cited by 667

  6. Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors

    Authors: Zhenguang Wang, Na Li, Kaichao Feng, Meixia Chen, Yan Zhang, Yang Liu, Qingming Yang, Jing Nie, Na Tang, Xingying Zhang, Chen Cheng, Lianjun Shen, Jiaping He, Xun Ye, Wei Cao, Haoyi Wang, Weidong Han - Cellular and Molecular Immunology 2021 cited by 257

  7. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells

    Authors: Xingying Zhang, Chenze Zhang, Miaomiao Qiao, Chen Cheng, Na Tang, Shan Lu, Wen Sun, Beilei Xu, Yuanwei Cao, Xiaofei Wei, Yao Wang, Weidong Han, Haoyi Wang - Cancer Cell 2022 cited by 164

  8. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents

    Authors: Xinbing Sui, Na Kong, Li Ye, Weidong Han, Jichun Zhou, Qin Zhang, Chao He, Hongming Pan - Cancer Letters 2013 cited by 960

  9. Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers

    Authors: Kaichao Feng, Yang Liu, Yelei Guo, Jingdan Qiu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Weidong Han - Protein & Cell 2017 cited by 316

  10. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

    Authors: Xinbing Sui, Ruo Bing Chen, Zheng Wang, Zhenzhen Huang, Na Kong, Mingxue Zhang, Weidong Han, Fang Lou, Jingjing Yang, Qi Zhang, Xian Wang, Chao He, Hongming Pan - Cell Death and Disease 2013 cited by 1,198

  11. Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

    Authors: Xiaolei Li, Changshun Shao, Yufang Shi, Weidong Han - Journal of Hematology & Oncology 2018 cited by 398

  12. CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial

    Authors: Yao Wang, Meixia Chen, Zhiqiang Wu, Chuan Tong, Hanren Dai, Yelei Guo, Yang Liu, Jianhua Huang, Haiyan Lv, Can Luo, Kaichao Feng, Qingming Yang, Xiaolei Li, Weidong Han - OncoImmunology 2018 cited by 328

  13. Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B cell lymphoma

    Authors: Chuan Tong, Yajing Zhang, Yang Liu, Xingyu Ji, Wenying Zhang, Yelei Guo, Han Xiao, Dongdong Ti, Hanren Dai, Chunmeng Wang, Qingming Yang, Wanli Liu, Yao Wang, Zhiqiang Wu, Weidong Han - Blood 2020 cited by 277

  14. Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation

    Authors: Yang Gao, Jianan Li, Wenfeng Cheng, Tian Diao, Huilan Liu, Yufei Bo, Chang Liu, Wei Zhou, Minmin Chen, Yuanyuan Zhang, Zhihua Liu, Weidong Han, Rufu Chen, Jirun Peng, Linnan Zhu, Wenhong Hou, Zemin Zhang - Cancer Cell 2024 cited by 241

  15. The role of STAT3 in autophagy

    Authors: Liangkun You, Zhanggui Wang, Hongsen Li, Jiawei Shou, Jing Zhao, Jiansheng Xie, Xinbing Sui, Hongming Pan, Weidong Han - Autophagy 2015 cited by 531

  16. Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers

    Authors: Yelei Guo, Kaichao Feng, Yang Liu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Hejin Jia, Weidong Han - Clinical Cancer Research 2017 cited by 257

  17. Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming

    Authors: Yao Wang, Chuan Tong, Hanren Dai, Zhiqiang Wu, Han Xiao, Yelei Guo, Deyun Chen, Jianshu Wei, Dongdong Ti, Zongzhi Liu, Qian Mei, Xiang Li, Liang Dong, Jing Nie, Yajing Zhang, Weidong Han - Nature Communications 2021 cited by 229

  18. Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

    Authors: Hanren Dai, Zhiqiang Wu, Hejin Jia, Chuan Tong, Yelei Guo, Dongdong Ti, Han Xiao, Yang Liu, Wenying Zhang, Chunmeng Wang, Yajing Zhang, Meixia Chen, Qingming Yang, Yao Wang, Weidong Han - Journal of Hematology & Oncology 2020 cited by 323

  19. Semi-Supervised Medical Report Generation via Graph-Guided Hybrid Feature Consistency

    Authors: Ke Zhang, Hanliang Jiang, Jian Zhang, Qingming Huang, Jianping Fan, Jun Yu, Weidong Han - IEEE Transactions on Multimedia, IEEE Trans. Multim. 2023 cited by 53

  20. Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia

    Authors: Quanshun Wang, Yao Wang, Haiyan Lv, Qingwang Han, Hui Fan, Bo Guo, Lili Wang, Weidong Han - Molecular Therapy 2014 cited by 414

  21. Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial

    Authors: Yang Liu, Yelei Guo, Zhiqiang Wu, Kaichao Feng, Chuan Tong, Yao Wang, Hanren Dai, Fengxia Shi, Qingming Yang, Weidong Han - Cytotherapy 2020 cited by 168

  22. Joint Embedding of Deep Visual and Semantic Features for Medical Image Report Generation

    Authors: Yan Yang, Jun Yu, Jian Zhang, Weidong Han, Hanliang Jiang, Qingming Huang - IEEE Transactions on Multimedia, IEEE Trans. Multim. 2021 cited by 69

  23. Roles of PFKFB3 in cancer

    Authors: Linlin Shi, Hongming Pan, Zhen Liu, Jiansheng Xie, Weidong Han - Signal Transduction and Targeted Therapy 2017 cited by 306

  24. Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy

    Authors: Han Xiao, Yao Wang, Jianshu Wei, Weidong Han - Journal of Hematology & Oncology 2019 cited by 195